Literature DB >> 7547760

HLA-G deletion polymorphism and pre-eclampsia/eclampsia.

K E Humphrey1, G A Harrison, D W Cooper, A N Wilton, S P Brennecke, B J Trudinger.   

Abstract

OBJECTIVE: To investigate a HLA-G deletion polymorphism in pre-eclamptic pedigrees and the general population.
DESIGN: A population association study of HLA-G genotypes from pre-eclamptic/eclamptic patients and control groups.
SETTING: Analyses undertaken in the School of Biological Sciences, Macquarie University. Patients were from Royal Women's Hospital, Melbourne, and controls were from Westmead Hospital and Macquarie University, Sydney.
SUBJECTS: One hundred and ninety-six individuals, consisting of 29 pre-eclamptic/eclamptic (PE/E) patients, 13 individuals born of a PE/E pregnancy, 46 blood relatives of PE/E patients, 21 husbands of PE/E patients, 25 women normotensive in first pregnancy, 15 husbands of women normotensive in first pregnancy and 47 staff and students of Macquarie University.
RESULTS: Genotypic and gene frequencies were not significantly different in the seven groups examined.
CONCLUSION: There is no detectable relationship between susceptibility to pre-eclampsia or being born of a pre-eclamptic pregnancy and HLA-G genotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547760     DOI: 10.1111/j.1471-0528.1995.tb11427.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  12 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

3.  A combination of single nucleotide polymorphisms in the 3'untranslated region of HLA-G is associated with preeclampsia.

Authors:  K Quach; S A Grover; S Kenigsberg; C L Librach
Journal:  Hum Immunol       Date:  2014-10-17       Impact factor: 2.850

Review 4.  HLA class Ib in pregnancy and pregnancy-related disorders.

Authors:  Gry Persson; Wenna Nascimento Melsted; Line Lynge Nilsson; Thomas Vauvert F Hviid
Journal:  Immunogenetics       Date:  2017-07-11       Impact factor: 2.846

Review 5.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

6.  Hypertension in pregnancy: new recommendations for management.

Authors:  R Shear; L Leduc; E Rey; J M Moutquin
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

7.  Variation in the HLA-G promoter region influences miscarriage rates.

Authors:  Carole Ober; Carrie L Aldrich; Inna Chervoneva; Christine Billstrand; Fedik Rahimov; Heather L Gray; Terry Hyslop
Journal:  Am J Hum Genet       Date:  2003-04-29       Impact factor: 11.025

8.  Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia.

Authors:  Jaana Heiskanen; Eeva-Liisa Romppanen; Mikko Hiltunen; Susan Iivonen; Arto Mannermaa; Kari Punnonen; Seppo Heinonen
Journal:  J Assist Reprod Genet       Date:  2002-05       Impact factor: 3.412

9.  A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2.

Authors:  E K Moses; J A Lade; G Guo; A N Wilton; M Grehan; K Freed; A Borg; J D Terwilliger; R North; D W Cooper; S P Brennecke
Journal:  Am J Hum Genet       Date:  2000-10-17       Impact factor: 11.043

10.  The 14 bp Del/Ins HLA-G polymorphism is related with high blood pressure in acute coronary syndrome and type 2 diabetes mellitus.

Authors:  Ilian Janet García-González; Yeminia Valle; Fernando Rivas; Luis Eduardo Figuera-Villanueva; José Francisco Muñoz-Valle; Hector Enrique Flores-Salinas; Bianca Ethel Gutiérrez-Amavizca; Nory Omayra Dávalos-Rodríguez; Jorge Ramón Padilla-Gutiérrez
Journal:  Biomed Res Int       Date:  2014-02-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.